Presentation, Treatment, and Outcome of Survivors of In-Hospital Versus Out-of-Hospital Sudden Cardiac Arrest.
Age Factors
Aged
Anti-Arrhythmia Agents
/ adverse effects
Atrial Fibrillation
/ epidemiology
Cause of Death
Comorbidity
Defibrillators, Implantable
Electrocardiography
Female
Heart Arrest
/ epidemiology
Humans
Male
Middle Aged
Mortality
Multivariate Analysis
Myocardial Infarction
/ complications
Myocardial Ischemia
/ complications
Out-of-Hospital Cardiac Arrest
/ epidemiology
Prognosis
Proportional Hazards Models
Renal Insufficiency, Chronic
/ epidemiology
Stroke Volume
Substance-Related Disorders
/ complications
Survivors
Tachycardia, Ventricular
/ etiology
Ventricular Fibrillation
/ etiology
Water-Electrolyte Imbalance
/ complications
Journal
The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277
Informations de publication
Date de publication:
15 04 2020
15 04 2020
Historique:
received:
29
11
2019
revised:
10
01
2020
accepted:
15
01
2020
pubmed:
26
2
2020
medline:
4
8
2020
entrez:
26
2
2020
Statut:
ppublish
Résumé
We examined the baseline characteristics, rates of implantable cardioverter defibrillator implantation, and long-term all-cause mortality for survivors of in-hospital (IHSCA) versus out-of-hospital (OHSCA) sudden cardiac arrest (SCA). A total of 1,433 SCA survivors (807 IHSCA and 626 OHSCA) from 2002 to 2012 were followed through February 2017. Baseline characteristics and potential triggers of SCA, including significant electrolyte and metabolic abnormalities and acute myocardial infarction and ischemia, were collected. Adjusted survival analyses were performed using a multivariate Cox model. The presence of SCA triggers was similar between IHSCA and OHSCA patients (39% vs 35%, p = 0.3), but OHSCA was more likely associated with cardiac ischemia and drug abuse, whereas IHSCA was more associated with new antiarrhythmic drugs (p <0.05). OHSCA survivors were more likely to receive an implantable cardioverter defibrillator (38% vs 18%, p <0.001). Over a median follow-up of 3.6 years, 674 (47%) patients died. After adjusting for unbalanced baseline characteristics, survival was similar between IHSCA and OHSCA survivors (hazard ratio 1.1, 95% confidence interval 0.9 to 1.3, p = 0.4). In conclusion, survivors of IHSCA and OHSCA differed in baseline characteristic, potential SCA triggers, and treatment interventions but their adjusted survival was comparable.
Identifiants
pubmed: 32093953
pii: S0002-9149(20)30048-5
doi: 10.1016/j.amjcard.2020.01.007
pii:
doi:
Substances chimiques
Anti-Arrhythmia Agents
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1137-1141Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.